Fibrin sealant patch - Takeda

Drug Profile

Fibrin sealant patch - Takeda

Alternative Names: Absorbable fibrin sealant patch; Fibrin-sealant; Medicated sponge - Nycomed; TachoComb; TachoSil

Latest Information Update: 25 Mar 2017

Price : $50

At a glance

  • Originator Nycomed
  • Developer Takeda Pharmaceuticals International GmbH
  • Class Acute-phase proteins; Adhesives; Antifibrinolytics; Antihaemorrhagics; Blood coagulation factors; Coagulants; Serine endopeptidases
  • Mechanism of Action Fibrinogen replacements; Thrombin replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Surgical blood loss

Most Recent Events

  • 03 Jun 2016 Baxalta has been acquired and merged into Shire
  • 29 Mar 2012 Nycomed is now called Takeda Pharmaceuticals International GmbH
  • 30 Sep 2011 Nycomed has been acquired by Takeda
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top